Brookfield Asset Management Inc. Catalent, Inc. Transaction History

Brookfield Asset Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Sep 25, 2023	BUY	$45.44 - $74.26 $497,976 - $813,815	10,959 New	10,959 $720,000
Q1 2023 May 15, 2023	SELL	$45.44 - $74.26 $2.09 Million - $3.42 Million	-46,047 Reduced 80.78%	10,959 $720,000
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $1.76 Million - $3.44 Million	42,513 Added 293.33%	57,006 $2.56 Million
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $1.05 Million - $1.64 Million	14,493 New	14,493 $1.05 Million
Q2 2021 Aug 17, 2021	BUY	$100.34 - $115.69 $3.59 Million - $4.14 Million	35,748 Added 196.85%	53,908 $5.83 Million
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $5.78 Million - $7.14 Million	-56,986 Reduced 75.83%	18,160 $1.91 Million
Q3 2020 Nov 16, 2020	SELL	$72.74 - $92.5 $402,033 - $511,247	-5,527 Reduced 6.85%	75,146 $6.44 Million
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $3.87 Million - $6.38 Million	80,673 New	80,673 $5.91 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.